 |
|
Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non–Small Cell Lung Cancer Cells
Mi Seong Kim, So Hui Kim, Sei-Hoon Yang, Min Seuk Kim
Tuberc Respir Dis. 2022;85(2):147-154. Published online 2021 Dec 1 DOI: https://doi.org/10.4046/trd.2021.0095
|
|
Citations to this article as recorded by
 Dysregulation of calcium homeostasis in cancer and its role in chemoresistance
Neema Kumari, Narasimha Pullaguri, Subha Narayan Rath, Ashish Bajaj, Vikas Sahu, Kranti Kiran Reddy Ealla
Cancer Drug Resistance.2024;[Epub] CrossRef Afatinib triggers a Ni2+‐resistant Ca2+ influx pathway in A549 non‐small cell lung cancer cells
Tien‐Yao Tsai, Cing‐Yu Chen, Lian‐Ru Shiao, Ting‐Tsz Ou, Cheng‐Hsun Wu, Yuk‐Man Leung, Louis W. C. Chow
Fundamental & Clinical Pharmacology.2023; 37(2): 253. CrossRef New Targeted Therapy for Non-Small Cell Lung Cancer
Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee
Tuberculosis and Respiratory Diseases.2023; 86(1): 1. CrossRef
|